Prof. Irmel A. Ayala

Pediatric Hematologist–Oncologist and Director of Hemophilia & Bleeding Disorders Treatment Center, Johns Hopkins All Children’s Hospital and Assistant Professor of Pediatrics at the University of South Florida, Florida, USA.

Prof. Irmel A. Ayala  specialized in Hematology/Oncology
Country

United States

Speciality
Hematology/Oncology
Subspeciality
Pediatric Hematology
Experience
40 years
Languages
English, Spanish

About the expert

Prof. Irmel A. Ayala is a pediatric hematologist-oncologist in St. Petersburg, Florida, USA, and Director of the Hemophilia and Bleeding Disorders Treatment Center at Johns Hopkins All Children’s Hospital. She has led multidisciplinary bleeding-disorder programs, served as institutional principal investigator for national surveillance and hemophilia research initiatives, and contributed to 16 journal publications and one Springer book chapter.

    Prof. Irmel A. Ayala earned her medical degree from the University of Puerto Rico School of Medicine in San Juan, Puerto Rico. She completed internship and residency training in pediatrics at San Juan City Hospital, followed by fellowship training in pediatric hematology/oncology at Emory University School of Medicine in Atlanta, Georgia.

    Prof. Ayala began her career in pediatric hematology/oncology at St. Joseph’s Children’s Hospital in Tampa, Florida, before joining Johns Hopkins All Children’s Hospital in St. Petersburg, Florida, USA. Her leadership roles have included Director of the Hemophilia Treatment Center, Medical Director of the 340B Hemophilia Program, Chief of the Division of Hematology/Oncology, and Chief of the Hematology Division within the Cancer and Blood Disorders Institute.

    Prof. Ayala established the federally supported Comprehensive Hemophilia Program and Bleeding Disorders Treatment Center at Johns Hopkins All Children’s Hospital. She also established or co-established multidisciplinary programs for pediatric thrombosis, bleeding disorders in young women, and immune dysregulation. Her research spans hemophilia surveillance, immune tolerance induction, pediatric venous thromboembolism risk, autoimmune cytopenias, and modern hemophilia prophylaxis outcomes.

    Prof. Ayala’s professional impact includes institutional principal-investigator roles in CDC, ATHN, HRSA-supported, and multicenter hemophilia studies. She is a member of leading hematology and thrombosis organizations, including the American Society of Pediatric Hematology/Oncology, the World Federation of Hemophilia, the Hemophilia and Thrombosis Research Society, and the International Society on Thrombosis and Haemostasis.

  • Chief

    2022 - 2024

    Hematology Division, Cancer & Blood Disorders Institute, JH All Children’s.

  • Founder & leader

    2015 - Today

    Young Women Bleeding Disorders/Menorrhagia Clinic.

  • Medical Director

    2010 - Today

    340B Hemophilia Program.

  • Chief

    2013 - 2017

    Division of Hematology/Oncology

  • Founder

    2007 - 2012

    Multidisciplinary Thrombosis Clinic.

  • Director

    2003 - Today

    Hemophilia & Bleeding Disorders Treatment Center (federally funded comprehensive program).

  • Board Certification, Pediatric Hematology/Oncology (ABP)

    1998

  • Board Certification, General Pediatrics (ABP): 1989

    1989

  • Fellowship, Pediatric Hematology/Oncology, Emory University, 1993.

  • Residency, Pediatrics

    San Juan City Hospital

    1989

  • MD

    University of Puerto Rico School of Medicine

    1986

  • Children’s Oncology Group — Associate Member. (1996)

  • American Society of Pediatric Hematology/Oncology. (2010)

  • World Federation of Hemophilia. (2006)

  • Hemophilia & Thrombosis Research Society. (2008)

  • International Society on Thrombosis and Haemostasis. (2017)

Other experts inthe same speciality

Dr. Gillian Clare Lowe  specialized in Hematology/Oncology

Dr. Gillian Clare Lowe

Consultant Haematologist, University Hospital Birmingham and Honorary Senior Clinical Lecturer, Institute of Cardiovascular Sciences, University of Birmingham, UK.

More about the expert
Prof. Ajay Vora   specialized in Hematology/Oncology

Prof. Ajay Vora

Honorary Professor of Paediatric Haematology at University of Sheffield and Consultant Paediatric Haematologist at Great Ormond Street Hospital, UK.

More about the expert
Prof. Ciro Rinaldi   specialized in Hematology/Oncology

Prof. Ciro Rinaldi

Professor of Haematology and Biomedical Science, University of Lincoln

More about the expert
Prof. Andrés José María Ferreri  specialized in Hematology/Oncology

Prof. Andrés José María Ferreri

Consultant Hematologist and Clinical Oncologist in IRCCS San Raffaele Scientific Institute

More about the expert
Dr. Karen Breen  specialized in Hematology/Oncology

Dr. Karen Breen

Consultant Hematologist at Guys and St Thomas’ NHS Foundation Trust, UK.

More about the expert
Prof. Prakash Satwani  specialized in Hematology/Oncology

Prof. Prakash Satwani

Professor of Pediatrics at Columbia University Irving Medical Center New York

More about the expert
Dr. Jesus Alcaraz Rubio  specialized in Hematology/Oncology

Dr. Jesus Alcaraz Rubio

Head of the Hematology Units at the Murcian Union of Hospitals, Spain

More about the expert
Prof. Michael Verneris  specialized in Hematology/Oncology

Prof. Michael Verneris

Professor in Hematology/Oncology & Bone Marrow Transplant in the Department of Pediatrics, Denver School of Medicine, University of Colorado, USA

More about the expert
Prof. Jakob R. Passweg  specialized in Hematology/Oncology

Prof. Jakob R. Passweg

Professor and Head of the Hematology Department, Basel University Hospital, Basel, Switzerland

More about the expert
Docspert news

Our network includes more than 1000 international experts in more than 1200 specialities and sub-specialities

See experts in all specialities
team map
Contact us
Docspert Health
Online